Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fda.gov

What's New: Drugs RSS Feed

Get the latest updates from What's New: Drugs RSS Feed directly as they happen.

Follow now 939 followers

Latest posts

Last updated 1 day ago

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

2 days ago

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new...

FDA Approves Stelara for Pediatric Ulcerative Colitis

2 days ago

The U.S. Food and Drug Administration has approved Stelara (ustekinumab) injection for...

Mitigating Risks from Human Xylazine Exposure - 10/04/2023

2 days ago

Mitigating Risks from Human Xylazine Exposure

Partnership for DSCSA Governance (PDG)/FDA Joint Public Meeting: DSCSA Stabilization Period Midway Checkpoint - 06/17/2024

2 days ago

This meeting serves as a checkpoint midway in the stabilization period, affording...

Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products - 05/19/2026

2 days ago

Learn directly from the FDA’s regulatory experts in medical product centers: drugs...

2024 PDA/ FDA Joint Regulatory Conference - 09/09/2024

2 days ago

The FDA and Parenteral Drug Association (PDA) are leveraging their combined strengths...

Advances in PBPK Modeling and its Regulatory Utility for Oral Drug Product Development - 10/12/2023

2 days ago

The applications of physiologically-based pharmacokinetic (PBPK) absorption modeling and simulation (M&S) have...

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - 03/05/2024

2 days ago

On March 5th, 2024, FDA is conducting a public workshop to discuss...

12th Annual Global Summit on Regulatory Science - 10/19/2022

2 days ago

12th Annual Global Summit on Regulatory Science. Registration for the Global Summit...

Patent Certifications and Suitability Petitions

2 days ago

Information on patents and suitability petitions that impact the availability of generic...